Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled studyJerrold L. Vitek, Philip A. Starr, Roshini Jain et al.|The Lancet Neurology|2020Cited by 155
Transdermal dopaminergic D<sub>2</sub> receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled studyJ. Thomas Hutton, Jerry L. Morris, Ali Samii et al.|Movement Disorders|2001Cited by 60
Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson DiseasePhilip A. Starr, Rajat S. Shivacharan, E. Matilda Goldberg et al.|JAMA Neurology|2025Cited by 21
Three-Year Follow-Up of a Prospective, Double Blinded Multi-Center RCT Evaluating DBS with a Multiple Source, Constant-Current Rechargeable System for Treatment of Parkinson's Disease (INTREPID)Philip A. Starr, Jerrold L. Vitek, Alexander I. Tröster et al.|Neurosurgery|2020Cited by 0